News Articles
Latest articles, insights, and updates from the blog.
Narcolepsy Masquerades as Depression—What Ketamine Patients Should Know
Narcolepsy is frequently mistaken for depression or ADHD, delaying diagnosis by 10–15 years. Here's what this means for ketamine therapy patients.
Moral Injury in Medicine: What It Means for Ketamine Care
New APA focus on moral injury in clinicians has direct implications for ketamine therapy access, provider quality, and patient-centered psychiatric care.
Why Some Depression Resists Treatment — And What Helps
Experts explain why standard antidepressants fail for many patients — and why faster, targeted treatments like ketamine are gaining ground in TRD care.
ASAM's New Youth SUD Standards: What Families Should Know
ASAM's updated adolescent SUD criteria emphasize early intervention and integrated mental health — here's what it means for families navigating youth treatment.
Telehealth Ketamine: Evolving Regulations
An overview of the changing regulatory landscape for telehealth-based ketamine prescribing, including federal policy, state-level rules, and safety considerations.
Key Ketamine Research Developments in 2025
A roundup of the most important ketamine research findings, clinical trials, and scientific developments shaping the field in 2025.
State-Level Ketamine Therapy Regulations: 2025 Landscape
An overview of the evolving state-level regulatory landscape for ketamine therapy in 2025, including telehealth rules, prescribing restrictions, and supervision requirements.
Ketamine Compounding Regulations in 2026: What Has Changed
An overview of the latest regulatory developments affecting compounded ketamine in 2026, including FDA enforcement updates, state-level changes, and the impact on patient access.
Ketamine Clinic Safety Standards: What Patients Should Expect
An overview of emerging safety standards for ketamine treatment clinics, including clinical protocols, monitoring requirements, provider qualifications, and what patients should look for when evaluating a ketamine provider.
International Ketamine Research: Global Developments and Discoveries
A roundup of significant ketamine research from around the world, including clinical trials, regulatory developments, and scientific discoveries outside the United States.
FDA Esketamine (Spravato) Updates
A summary of the latest FDA regulatory actions, label updates, and clinical developments related to esketamine (Spravato) for depression treatment.
Ketamine Insurance Coverage: 2025 Trends and Developments
A look at the evolving insurance landscape for ketamine therapy in 2025, including Spravato coverage changes, off-label coverage, and what patients should know.
Ready to learn more?
Explore our comprehensive guides and tools to help you navigate your ketamine therapy journey.